欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/2023/001
药品名称Gemcitabine Strides 38 mg/ml powder for solution for infusion
活性成分
    • gemcitabine 38.0 mg/ml
剂型Powder for solution for infusion
上市许可持有人Strides Arcolab International Ltd. - Watford - WD 189 SS - Verenigd Koninkrijk
参考成员国 - 产品名称Netherlands (NL)
Gemcitabine Strides
互认成员国 - 产品名称
    • Germany (DE)
    • Belgium (BE)
    • Iceland (IS)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
    • Bulgaria (BG)
    • Romania (RO)
    • Slovakia (SK)
    • Denmark (DK)
    • United Kingdom (Northern Ireland) (XI)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
    • Hungary (HU)
      Gemcitabin Strides 38mg/ml por oldatos infúzióhoz
    • Cyprus (CY)
      gemcitabine strides pwd for sol for inf
    • Slovenia (SI)
      Gemcitabin Strides Arcolab International 38 mg/ml prašek za raztopino za infundiranje
    • Malta (MT)
      Gemcitabine Strides Pdr for Soln for Infusion 38mg/ml
许可日期2011/11/14
最近更新日期2020/03/18
药物ATC编码
    • L01BC05 gemcitabine
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase